News : 2011 : March

Claes Wahlestedt, M.D., Ph.D.

Drug Discovery Pioneer and Biotech Entrepreneur Joins Miller School Faculty and Leadership

An internationally recognized researcher of novel drug therapies for neuropsychiatric disorders and epigenetics has joined the Miller School faculty and leadership, bringing his team, his wealth of discovery and his drive to find new treatments for autism, Alzheimer’s, schizophrenia, depression, addiction, Parkinson’s, macular degeneration and other human disorders.

Read more »